Total Payments
$23,480
2024 Payments
$3,716
Companies
72
Transactions
1,124
Medicare Patients
2,067
Medicare Billing
$293,863
Payment Breakdown by Category
Food & Beverage$23,154 (98.6%)
Education$204.35 (0.9%)
Other$86.52 (0.4%)
Gifts$34.75 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $23,154 | 1,106 | 98.6% |
| Education | $204.35 | 9 | 0.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $86.52 | 6 | 0.4% |
| Gift | $34.75 | 3 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,414 | 124 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $2,406 | 155 | $0 (2024) |
| Biogen, Inc. | $1,410 | 75 | $0 (2024) |
| Genentech USA, Inc. | $1,342 | 42 | $0 (2024) |
| EMD Serono, Inc. | $1,201 | 50 | $0 (2024) |
| UCB, Inc. | $1,122 | 53 | $0 (2024) |
| Eisai Inc. | $1,080 | 40 | $0 (2024) |
| Amgen Inc. | $791.22 | 44 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $731.48 | 20 | $0 (2022) |
| Supernus Pharmaceuticals, Inc. | $675.65 | 39 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $3,716 | 149 | Eisai Inc. ($466.78) |
| 2023 | $3,233 | 148 | ABBVIE INC. ($573.42) |
| 2022 | $3,516 | 164 | ABBVIE INC. ($872.45) |
| 2021 | $3,264 | 198 | AbbVie Inc. ($558.11) |
| 2020 | $1,394 | 60 | Novartis Pharmaceuticals Corporation ($185.77) |
| 2019 | $4,020 | 198 | EMD Serono, Inc. ($640.85) |
| 2018 | $2,336 | 114 | Genentech USA, Inc. ($338.15) |
| 2017 | $2,002 | 93 | Novartis Pharmaceuticals Corporation ($422.16) |
All Payment Transactions
1,124 individual payment records from CMS Open Payments — Page 1 of 45
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $16.02 | General |
| Category: Neurology | ||||||
| 12/19/2024 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: EPILEPSY | ||||||
| 12/16/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $31.92 | General |
| Category: Neurology | ||||||
| 12/12/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $5.20 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/11/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 11/25/2024 | Genentech USA, Inc. | Ocrevus Zunovo (Biological) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: Immunology | ||||||
| 11/20/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: PAIN | ||||||
| 11/19/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | Cash or cash equivalent | $120.60 | General |
| Category: Neurology | ||||||
| 11/14/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $21.46 | General |
| Category: Neuroscience | ||||||
| 11/13/2024 | CATALYST PHARMACEUTICALS, INC. | FYCOMPA (Drug) | Education | Cash or cash equivalent | $16.72 | General |
| Category: NEUROLOGY | ||||||
| 11/07/2024 | Amgen Inc. | UPLIZNA (Biological) | Food and Beverage | In-kind items and services | $19.04 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/07/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $13.09 | General |
| Category: Narcoplepsy | ||||||
| 11/06/2024 | Biogen, Inc. | VUMERITY (Drug) | Food and Beverage | In-kind items and services | $23.37 | General |
| Category: Neurology | ||||||
| 11/04/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $31.92 | General |
| Category: Neurology | ||||||
| 11/04/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $16.60 | General |
| Category: Neuroscience | ||||||
| 10/29/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Neurology | ||||||
| 10/28/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $22.38 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/22/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $108.32 | General |
| Category: Neuroscience | ||||||
| 10/16/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $25.73 | General |
| Category: Neuroscience | ||||||
| 10/16/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $8.22 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 10/14/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $22.66 | General |
| Category: Neurology | ||||||
| 10/11/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: Neurology | ||||||
| 10/11/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $13.79 | General |
| Category: Neurology | ||||||
| 10/10/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: Neurology | ||||||
| 10/07/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $22.50 | General |
| Category: NEUROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 420 | 813 | $127,762 | $64,254 |
| 2022 | 9 | 500 | 1,023 | $158,358 | $80,785 |
| 2021 | 8 | 560 | 1,080 | $164,055 | $89,557 |
| 2020 | 11 | 587 | 1,061 | $144,310 | $59,267 |
Total Patients
2,067
Total Services
3,977
Medicare Billing
$293,863
Procedure Codes
35
All Medicare Procedures & Services
35 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 223 | 581 | $88,893 | $48,234 | 54.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 91 | 91 | $19,110 | $10,059 | 52.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 31 | 49 | $5,929 | $2,765 | 46.6% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Facility | 2023 | 33 | 45 | $6,165 | $1,525 | 24.7% |
| 95910 | Nerve conduction, 7-8 studies | Facility | 2023 | 15 | 15 | $4,770 | $1,157 | 24.2% |
| 95812 | Measurement of brain wave activity (eeg), 41-60 minutes | Facility | 2023 | 11 | 11 | $2,475 | $336.72 | 13.6% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 16 | 21 | $420.00 | $176.40 | 42.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 242 | 721 | $110,313 | $61,483 | 55.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 103 | 103 | $21,630 | $11,395 | 52.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 37 | 56 | $6,776 | $3,136 | 46.3% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Facility | 2022 | 29 | 43 | $5,891 | $1,379 | 23.4% |
| 95910 | Nerve conduction, 7-8 studies | Facility | 2022 | 16 | 16 | $5,088 | $1,282 | 25.2% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2022 | 27 | 27 | $3,789 | $1,087 | 28.7% |
| 92540 | Evaluation and testing for balance with recording | Facility | 2022 | 13 | 13 | $3,029 | $664.93 | 22.0% |
| 92537 | Test to assess balance during warm and cool irrigation in both ears | Facility | 2022 | 13 | 13 | $1,222 | $265.52 | 21.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 20 | 31 | $620.00 | $91.59 | 14.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 241 | 670 | $102,510 | $63,384 | 61.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 118 | 118 | $24,780 | $13,876 | 56.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 96 | 154 | $18,634 | $7,074 | 38.0% |
| 95816 | Measurement and recording of brain wave (eeg) activity, awake and drowsy | Facility | 2021 | 30 | 35 | $5,111 | $1,506 | 29.5% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Facility | 2021 | 25 | 38 | $5,206 | $1,352 | 26.0% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2021 | 21 | 33 | $3,300 | $1,227 | 37.2% |
| 95910 | Nerve transmission studies, 7-8 studies | Facility | 2021 | 12 | 13 | $4,134 | $1,081 | 26.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 17 | 19 | $380.00 | $57.00 | 15.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 255 | 685 | $82,885 | $33,368 | 40.3% |
About Dr. David Lee, MD
Dr. David Lee, MD is a Neurology healthcare provider based in Cape Girardeau, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1861505703.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Lee, MD has received a total of $23,480 in payments from pharmaceutical and medical device companies, with $3,716 received in 2024. These payments were reported across 1,124 transactions from 72 companies. The most common payment nature is "Food and Beverage" ($23,154).
As a Medicare-enrolled provider, Lee has provided services to 2,067 Medicare beneficiaries, totaling 3,977 services with total Medicare billing of $293,863. Data is available for 4 years (2020–2023), covering 35 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Cape Girardeau, MO
- Active Since 08/16/2006
- Last Updated 04/24/2024
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1861505703
Products in Payments
- UBRELVY (Drug) $1,452
- KESIMPTA (Drug) $934.70
- OCREVUS (Biological) $843.85
- QULIPTA (Drug) $726.01
- Briviact (Drug) $698.49
- APTIOM (Drug) $644.32
- ZEPOSIA (Drug) $624.97
- Aimovig (Biological) $594.34
- GILENYA (Drug) $594.28
- TYSABRI (Biological) $513.99
- NURTEC ODT (Drug) $513.97
- Leqembi (Drug) $490.70
- MAYZENT (Drug) $472.02
- Fycompa (Drug) $466.05
- AUSTEDO (Drug) $405.81
- TROKENDI XR (Drug) $392.22
- EPIDIOLEX (Drug) $378.46
- NUPLAZID (Drug) $369.65
- Ponvory (Drug) $369.02
- AUBAGIO (Drug) $355.01
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Cape Girardeau
Robert Gardner, Md, MD
Neurology — Payments: $103,392
Neurology $103,392
Dr. Randall Stahly, D.o, D.O
Neurology — Payments: $8,008
Neurology $8,008
James Laguardia, M.d, M.D
Neurology — Payments: $4,860
Neurology $4,860
Dr. Aleksey Androsov, M.d, M.D
Neurology — Payments: $4,536
Neurology $4,536
Dr. Mark Farrenburg, M.d, M.D
Neurology — Payments: $2,221
Neurology $2,221
Richard Ronca
Neurology — Payments: $413.49
Neurology $413.49